858
R. Pellicciari et al. / Il Farmaco 58 (2003) 851ꢀ858
/
(
1997) 1089ꢀ
/
1095;
proteins. Samples were centrifuged at 14,000 rpm for 50
min. Surnatantes were removed and after washing two
(
b) C.M. Simbulan-Rosenthal, D.S. Rosenthal, R. Luo, J.H. Li, J.
Zhang, M.E. Smulson, Inhibition of poly(ADP-ribose) polymer-
times with 1 ml of ddH O, pellets were resuspended in
2
ase activity is insufficient to induce tetraploidy, Nucleic Acids
5
00 ml of toluene and incubated at 37 8C for 1 h. CPMs
Res. 29 (2001) 841ꢀ849.
[7] M. Banasik, H. Komura, M. Shimoyama, K. Ueda, Specific
/
were counted (3 min) after adding 4 ml of Liquid
Scintillation Cocktail to each sample.
inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribo-
syl)transferase, J. Biol. Chem. 267 (1992) 1569ꢀ1575.
/
[
8] R.J. Griffin, S. Srinivasan, K. Bowman, A.H. Calvert, N.J.
Curtin, D.R. Newell, L.C. Pemberton, B.T. Golding, Resis-
tance-modifying agents. 5. Synthesis and biological properties of
quinazolinone inhibitors of the DNA repair enzyme poly(ADP-
7
.2. Middle cerebral artery occlusion (MCAO)
The infarction volume was measured 72 h after
occlusion according to Cozzi et al. [17].
ribose) polymerase (PARP), J. Med. Chem. 41 (1998) 5247ꢀ5256.
/
[
9] A.W. White, R. Almassy, A.H. Calvert, N.J. Curtin, R.J. Griffin,
Z. Hostomsky, K. Maegley, D.R. Newell, S. Srinivasan, B.T.
Golding, Resistance-modifying agents. 9. (1) Synthesis and
biological properties of benzimidazole inhibitors of the DNA
repair enzyme Poly(ADP-ribose) polymerase, J. Med. Chem. 43
References
[
[
[
[
[
1] G. de Murcia, J. Menissier de Murcia, Poly(ADPribose) poly-
merase: a molecular nick-sensor, Trends Biochem. Sci. 19 (1994)
(
2000) 4084ꢀ
10] A. Ruf, G. De Murcia, G.E. Schulz, Inhibitor and NADꢁ
binding to poly(ADP-ribose) polymerase as derived from crystal
structures and homology modeling, Biochemistry 37 (1998) 3893ꢀ
900.
/
4097.
[
/
1
72ꢀ176.
/
2] S. Shall, G. de Murcia, Poly(ADP-ribose) polymerase-1: what
have we learned from the deficient mouse model?, Mutat. Res. 460
/
3
(
2000) 1ꢀ15.
/
[
11] G. Costantino, A. Macchiarulo, E. Camaioni, R. Pellicciari,
Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors.
3] A.A. Pieper, A. Verma, J. Zhang, S.H. Snyder, Poly (ADP-ribose)
polymerase, nitric oxide and cell death, Trends Pharmacol. Sci. 20
Docking of ligands and quantitative structureꢀ
ship analysis, J. Med. Chem. 44 (2001) 3786ꢀ3794.
12] N. Gjøs, S. Gronowitz, Some substitution reactions of 3-
phenylthiophene, Acta Chem. Scand. 24 (1970) 99ꢀ104.
13] S. Gronowitz, N. Gjøs, On the bromination of 3-phenylthio-
phene, J. Org. Chem. 32 (1967) 463ꢀ464.
/activity relation-
(
1999) 171ꢀ181.
/
/
4] C. Szabo, V.L. Dawson, Role of poly(ADP-ribose) synthetase in
inflammation and ischaemia-reperfusion, Trends Pharmacol. Sci.
[
[
[
/
1
9 (1998) 287ꢀ298.
/
5] (a) E.H. Lo, P. Bosque-Hamilton, W. Meng, Inhibition of
poly(ADP-ribose) polymerase: reduction of ischemic injury and
/
14] K. Ito, K. Yakushijin, S. Yoshina, A. Tanaka, K. Yamamoto,
attenuation of N-methyl-
dysregulation, Stroke 29 (1998) 830ꢀ
b) K. Takahashi, A.A. Pieper, S.E. Croul, J. Zhang, S.H. Snyder,
D
-aspartate-induced neurotransmitter
Synthesis of furo[2,3-c]isoquinoline derivatives, J. Heterocycl.
/836;
Chem. 15 (1978) 301ꢀ305.
15] S. Tsuzuki, K. Honda, R. Azumi, Model chemistry calculations of
/
(
[
J.H. Greenberg, Post-treatment with an inhibitor of poly(ADP-
ribose) polymerase attenuates cerebral damage in focal ischemia,
thiophene dimer interactions: origin of pi-stacking, J. Am. Chem.
Soc. 124 (2002) 12200ꢀ12209.
/
Brain Res. 829 (1999) 46ꢀ
/54;
[
16] S. Tsuzuki, K. Honda, T. Uchimaru, M. Mikami, K. Tanabe,
Origin of attraction and directionality of the pi/pi interaction:
model chemistry calculations of benzene dimer interaction, J. Am.
(c) K. Plaschke, J. Kopitz, M.A. Weigand, E. Martin, H.J.
Bardenheuer, The neuroprotective effect of cerebral poly(ADP-
ribose)polymerase inhibition in a rat model of global ischemia,
Chem. Soc. 124 (2002) 104ꢀ112.
/
Neurosci. Lett. 284 (2000) 109ꢀ
/112;
[
17] A. Cozzi, R. Carpenedo, F. Moroni, Kynurenine hydroxylase
inhibitors reduce ischemic brain damage: studies with (m-nitro-
benzoyl)-alanine (mNBA) and 3,4-dimethoxy-[N-4-(nitrophe-
nyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of
focal or global brain ischemia, J. Cereb. Blood Flow Metab. 19
(d) G.E. Abdelkarim, K. Gertz, C. Harms, J. Katchanov, U.
Dirnagl, C. Szabo, M. Endres, Protective effects of PJ34, a novel,
potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in
vitro and in vivo models of stroke, Int. J. Mol. Med. 7 (2001)
2
55ꢀ
/
260;
e) F. Moroni, E. Meli, F. Peruginelli, A. Chiarugi, A. Cozzi, R.
(
1999) 771ꢀ777.
/
(
[
18] C.L. Arcus, G.C. Barrett, Reactions of organic azides, Part IX.
Ring-expansions leading to 2-phenyl-(iso)quinolono- and
Picca, P. Romagnoli, R. Pellicciari, D.E. Pellegrini-Giampietro,
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but
not apoptotic neuronal death in experimental models of cerebral
(iso)quinolino-(4?,3?-4,5)thiazole
2,3)thiophen: attempted rearrangements of fluorenone hydrazone,
J. Chem. Soc. 1960, 2098ꢀ2102.
and
(iso)quinolono(3?,4?-
ischemia, Cell. Death Differ. 8 (2001) 921ꢀ932.
/
[
6] (a) M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J.
Traystman, J. Bao, A. Pieper, Z.Q. Wang, T.M. Dawson, S.H.
Snyder, V.L. Dawson, Poly(ADP-ribose) polymerase gene dis-
ruption renders mice resistant to cerebral ischemia, Nature Med. 3
/
[19] C.L. Arcus, G.C. Barrett, Reactions of organic azides, Part X.
The Schmidt reaction with 3?-oxoindeo(2?,1?-2,3)thiophen: the
structure of the product, J. Chem. Soc. 1961, 1408ꢀ1409.
/